MicroTransponder, Inc.
MicroTransponder is dedicated to improving the quality of life for patients with chronic neurological conditions through its innovative Paired Vagus Nerve Stimulation (VNS) platform. Their FDA-approved Vivistim System aims to help stroke survivors regain arm and hand motor function by leveraging neuroplasticity. The company emphasizes patient-centered care, embracing challenges, and maintaining flexibility in its operations. With a strong leadership team and a commitment to compliance and innovation, MicroTransponder continues to advance stroke rehabilitation technology.
Industries
Nr. of Employees
small (1-50)
MicroTransponder, Inc.
Dallas, Texas, United States, North America
Products
Implantable paired vagus nerve stimulation system for post-stroke upper-limb rehabilitation
An implantable neurostimulation system designed to stimulate the vagus nerve in coordination with rehabilitation exercises to improve hand and arm motor function in chronic ischemic stroke patients.
Implantable paired vagus nerve stimulation system for post-stroke upper-limb rehabilitation
An implantable neurostimulation system designed to stimulate the vagus nerve in coordination with rehabilitation exercises to improve hand and arm motor function in chronic ischemic stroke patients.
Services
Clinical trial design and execution
Design and conduct of randomized pivotal trials and registries for neuromodulation therapies, including trial operations and publication support.
Regulatory affairs and submission support
Preparation and management of FDA PMA and IDE submissions and interactions with regulatory authorities for implantable neurostimulation devices.
Reimbursement and market access consulting
Development of payer engagement strategies, coding solutions, and applications for CMS and commercial coverage.
Clinician and surgical training
Provision of training for surgeons and rehabilitation clinicians on implantation procedures and paired-stimulation therapy delivery, including facility-based sessions.
Compliance program development
Establishment of written policies, training, auditing, and reporting mechanisms to align promotional activities with federal and state legal requirements and industry codes.
Clinical trial design and execution
Design and conduct of randomized pivotal trials and registries for neuromodulation therapies, including trial operations and publication support.
Regulatory affairs and submission support
Preparation and management of FDA PMA and IDE submissions and interactions with regulatory authorities for implantable neurostimulation devices.
Reimbursement and market access consulting
Development of payer engagement strategies, coding solutions, and applications for CMS and commercial coverage.
Clinician and surgical training
Provision of training for surgeons and rehabilitation clinicians on implantation procedures and paired-stimulation therapy delivery, including facility-based sessions.
Compliance program development
Establishment of written policies, training, auditing, and reporting mechanisms to align promotional activities with federal and state legal requirements and industry codes.
Expertise Areas
- Stroke rehabilitation neuromodulation
- Clinical trial management for implantable devices
- Regulatory affairs (PMA and IDE pathways)
- Reimbursement and market access strategy
Key Technologies
- Vagus nerve stimulation (VNS)
- Implantable neurostimulation systems
- Implantable peripheral nerve leads
- Paired stimulation synchronized with therapy/training